XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.25.1

Financial Assets And Financial Liabilities | 3 Months Ended
--- | ---
Mar. 31, 2025
Financial Assets And Financial Liabilities [Abstract] |
Financial Assets And Financial Liabilities | 6. Financial Assets and Financial Liabilities Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis The tables below present, by level within the fair value hierarchy (see Note 2), financial assets and liabilities, measured at fair value on a recurring basis for the periods indicated. As required by ASC Topic 820, financial assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the respective fair value measurement.
|  | Financial Assets at Fair Value as of March 31, 2025
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total
|  | (in millions)
Securities segregated for regulatory purposes |  |  |  |  |  |  |  |  |  |  |  |
U.S. and foreign government securities |  | $ | 6,361 |  | $ | — |  | $ | — |  | $ | 6,361
Municipal securities |  |  | — |  |  | 33 |  |  | — |  |  | 33
Total securities segregated for regulatory purposes |  |  | 6,361 |  |  | 33 |  |  | — |  |  | 6,394
Financial instruments owned, at fair value |  |  |  |  |  |  |  |  |  |  |  |
Stocks |  |  | 2,296 |  |  | — |  |  | — |  |  | 2,296
Options |  |  | 152 |  |  | — |  |  | — |  |  | 152
U.S. and foreign government securities |  |  | 928 |  |  | — |  |  | — |  |  | 928
Mutual funds |  |  | 2 |  |  | — |  |  | — |  |  | 2
Precious metals |  |  | — |  |  | 27 |  |  | — |  |  | 27
Currency forward contracts |  |  | — |  |  | 1 |  |  | — |  |  | 1
Total financial instruments owned, at fair value |  |  | 3,378 |  |  | 28 |  |  | — |  |  | 3,406
Other assets |  |  |  |  |  |  |  |  |  |  |  |
Customer-held fractional shares |  |  | 279 |  |  | — |  |  | — |  |  | 279
Other investments in equity securities |  |  | 43 |  |  | — |  |  | — |  |  | 43
Total other assets |  |  | 322 |  |  | — |  |  | — |  |  | 322
Total financial assets at fair value |  | $ | 10,061 |  | $ | 61 |  | $ | — |  | $ | 10,122
|  | Financial Liabilities at Fair Value as of March 31, 2025
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total
|  | (in millions)
Financial instruments sold, but not yet purchased, at fair value |  |  |  |  |  |  |  |  |  |  |  |
Stocks |  | $ | 112 |  | $ | — |  | $ | — |  | $ | 112
Options |  |  | 100 |  |  | — |  |  | — |  |  | 100
Precious metals |  |  | — |  |  | 23 |  |  | — |  |  | 23
Currency forward contracts |  |  | — |  |  | 17 |  |  | — |  |  | 17
Total financial instruments sold, but not yet purchased, at fair value |  |  | 212 |  |  | 40 |  |  | — |  |  | 252
Accounts payable, accrued expenses and other liabilities |  |  |  |  |  |  |  |  |  |  |  |
Fractional shares repurchase obligation |  |  | 279 |  |  | — |  |  | — |  |  | 279
Total accounts payable, accrued expenses and other liabilities |  |  | 279 |  |  | — |  |  | — |  |  | 279
Total financial liabilities at fair value |  | $ | 491 |  | $ | 40 |  | $ | — |  | $ | 531
‎
|  | Financial Assets at Fair Value as of December 31, 2024
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total
|  | (in millions)
Securities segregated for regulatory purposes |  |  |  |  |  |  |  |  |  |  |  |
U.S. and foreign government securities |  | $ | 6,460 |  | $ | — |  | $ | — |  | $ | 6,460
Municipal securities |  |  | — |  |  | 33 |  |  | — |  |  | 33
Total securities segregated for regulatory purposes |  |  | 6,460 |  |  | 33 |  |  | — |  |  | 6,493
Financial instruments owned, at fair value |  |  |  |  |  |  |  |  |  |  |  |
Stocks |  |  | 1,763 |  |  | — |  |  | — |  |  | 1,763
Options |  |  | 84 |  |  | — |  |  | — |  |  | 84
U.S. and foreign government securities |  |  | 54 |  |  | — |  |  | — |  |  | 54
Mutual funds |  |  | 2 |  |  | — |  |  | — |  |  | 2
Precious metals |  |  | — |  |  | 21 |  |  | — |  |  | 21
Currency forward contracts |  |  | — |  |  | — |  |  | — |  |  | —
Total financial instruments owned, at fair value |  |  | 1,903 |  |  | 21 |  |  | — |  |  | 1,924
Other assets |  |  |  |  |  |  |  |  |  |  |  |
Customer-held fractional shares |  |  | 260 |  |  | — |  |  | — |  |  | 260
Other investments in equity securities |  |  | 32 |  |  | — |  |  | — |  |  | 32
Total other assets |  |  | 292 |  |  | — |  |  | — |  |  | 292
Total financial assets at fair value |  | $ | 8,655 |  | $ | 54 |  | $ | — |  | $ | 8,709
|  | Financial Liabilities at Fair Value as of December 31, 2024
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total
|  | (in millions)
Financial instruments sold, but not yet purchased, at fair value |  |  |  |  |  |  |  |  |  |  |  |
Stocks |  | $ | 116 |  | $ | — |  | $ | — |  | $ | 116
Options |  |  | 96 |  |  | — |  |  | — |  |  | 96
Precious metals |  |  | — |  |  | 18 |  |  | — |  |  | 18
Currency forward contracts |  |  | — |  |  | 63 |  |  | — |  |  | 63
Total financial instruments sold, but not yet purchased, at fair value |  |  | 212 |  |  | 81 |  |  | — |  |  | 293
Accounts payable, accrued expenses and other liabilities |  |  |  |  |  |  |  |  |  |  |  |
Fractional shares repurchase obligation |  |  | 260 |  |  | — |  |  | — |  |  | 260
Total accounts payable, accrued expenses and other liabilities |  |  | 260 |  |  | — |  |  | — |  |  | 260
Total financial liabilities at fair value |  | $ | 472 |  | $ | 81 |  | $ | — |  | $ | 553
Level 3 Financial Assets and Financial Liabilities There were no transfers in or out of level 3 for the three months ended March 31, 2025. ‎ Financial Assets and Liabilities Not Measured at Fair Value Financial assets and liabilities not measured at fair value are recorded at carrying value, which approximates fair value due to their short-term nature. The tables below represent the carrying value, fair value and fair value hierarchy category of certain financial assets and liabilities that are not recorded at fair value in the Company's condensed consolidated statements of financial condition for the periods indicated. The tables below exclude certain financial instruments such as equity method investments and all non-financial assets and liabilities.
|  | March 31, 2025
|  | Carrying ‎Value |  | Fair ‎Value |  | Level 1 |  | Level 2 |  | Level 3
|  | (in millions)
Financial assets, not measured at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 3,500 |  | $ | 3,500 |  | $ | 3,500 |  | $ | — |  | $ | —
Cash - segregated for regulatory purposes |  |  | 39,173 |  |  | 39,173 |  |  | 39,173 |  |  | — |  |  | —
Securities - segregated for regulatory purposes |  |  | 23,000 |  |  | 23,000 |  |  | — |  |  | 23,000 |  |  | —
Securities borrowed |  |  | 5,845 |  |  | 5,845 |  |  | — |  |  | 5,845 |  |  | —
Securities purchased under agreements to resell |  |  | 8,376 |  |  | 8,376 |  |  | — |  |  | 8,376 |  |  | —
Receivables from customers |  |  | 63,857 |  |  | 63,857 |  |  | — |  |  | 63,857 |  |  | —
Receivables from brokers, dealers and clearing organizations |  |  | 2,495 |  |  | 2,495 |  |  | — |  |  | 2,495 |  |  | —
Interest receivable |  |  | 443 |  |  | 443 |  |  | — |  |  | 443 |  |  | —
Other assets |  |  | 40 |  |  | 42 |  |  | — |  |  | 3 |  |  | 39
Total financial assets, not measured at fair value |  | $ | 146,729 |  | $ | 146,731 |  | $ | 42,673 |  | $ | 104,019 |  | $ | 39
Financial liabilities, not measured at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short-term borrowings |  | $ | 12 |  | $ | 12 |  | $ | — |  | $ | 12 |  | $ | —
Securities loaned |  |  | 16,894 |  |  | 16,894 |  |  | — |  |  | 16,894 |  |  | —
Payables to customers |  |  | 120,654 |  |  | 120,654 |  |  | — |  |  | 120,654 |  |  | —
Payables to brokers, dealers and clearing organizations |  |  | 1,226 |  |  | 1,226 |  |  | — |  |  | 1,226 |  |  | —
Interest payable |  |  | 297 |  |  | 297 |  |  | — |  |  | 297 |  |  | —
Total financial liabilities, not measured at fair value |  | $ | 139,083 |  | $ | 139,083 |  | $ | — |  | $ | 139,083 |  | $ | —
‎
|  | December 31, 2024
|  | Carrying ‎Value |  | Fair ‎Value |  | Level 1 |  | Level 2 |  | Level 3
|  | (in millions)
Financial assets, not measured at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 3,633 |  | $ | 3,633 |  | $ | 3,633 |  | $ | — |  | $ | —
Cash - segregated for regulatory purposes |  |  | 36,600 |  |  | 36,600 |  |  | 36,600 |  |  | — |  |  | —
Securities - segregated for regulatory purposes |  |  | 21,353 |  |  | 21,353 |  |  | — |  |  | 21,353 |  |  | —
Securities borrowed |  |  | 5,369 |  |  | 5,369 |  |  | — |  |  | 5,369 |  |  | —
Securities purchased under agreements to resell |  |  | 6,575 |  |  | 6,575 |  |  | — |  |  | 6,575 |  |  | —
Receivables from customers |  |  | 64,432 |  |  | 64,432 |  |  | — |  |  | 64,432 |  |  | —
Receivables from brokers, dealers and clearing organizations |  |  | 2,196 |  |  | 2,196 |  |  | — |  |  | 2,196 |  |  | —
Interest receivable |  |  | 446 |  |  | 446 |  |  | — |  |  | 446 |  |  | —
Other assets |  |  | 30 |  |  | 32 |  |  | — |  |  | 3 |  |  | 29
Total financial assets, not measured at fair value |  | $ | 140,634 |  | $ | 140,636 |  | $ | 40,233 |  | $ | 100,374 |  | $ | 29
Financial liabilities, not measured at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Short-term borrowings |  | $ | 14 |  | $ | 14 |  | $ | — |  | $ | 14 |  | $ | —
Securities loaned |  |  | 16,248 |  |  | 16,248 |  |  | — |  |  | 16,248 |  |  | —
Payables to customers |  |  | 115,343 |  |  | 115,343 |  |  | — |  |  | 115,343 |  |  | —
Payables to brokers, dealers and clearing organizations |  |  | 476 |  |  | 476 |  |  | — |  |  | 476 |  |  | —
Interest payable |  |  | 311 |  |  | 311 |  |  | — |  |  | 311 |  |  | —
Total financial liabilities, not measured at fair value |  | $ | 132,392 |  | $ | 132,392 |  | $ | — |  | $ | 132,392 |  | $ | —
‎ Netting of Financial Assets and Financial Liabilities The Company’s policy is to net securities borrowed and securities loaned, and securities purchased under agreements to resell and securities sold under agreements to repurchase that meet the offsetting requirements prescribed in ASC Topic 210-20. In the tables below, the amounts of financial instruments that are not offset in the condensed consolidated statements of financial condition, but could be netted against cash or financial instruments with specific counterparties under master netting agreements, according to the terms of the agreements, including clearing houses (exchange-traded options, warrants and discount certificates) or over the counter currency forward contract counterparties, are presented to provide financial statement readers with the Company’s net payable or receivable with counterparties for these financial instruments. The tables below present the netting of financial assets and financial liabilities for the periods indicated.
|  | March 31, 2025
|  |  |  |  |  | Amounts |  |  | Net Amounts |  | Amounts Not Offset |  |  |
|  | Gross |  | Offset in the |  |  | Presented in |  | in the Condensed |  |  |
|  | Amounts |  | Condensed |  |  | the Condensed |  | Consolidated |  |  |
|  | of Financial |  | Consolidated |  |  | Consolidated |  | Statements of |  |  |
|  | Assets and |  | Statements of |  |  | Statements of |  | Financial Condition |  |  |
|  | Liabilities |  | Financial |  |  | Financial |  | Cash or Financial |  | Net
|  | Recognized |  | Condition | 2 |  | Condition |  | Instruments |  | Amount
|  | (in millions)
Offsetting of financial assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities segregated for regulatory purposes: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segregated securities purchased under agreements to resell |  | $ | 22,860 | 1 |  | $ | — |  |  | $ | 22,860 |  | $ | (22,860) |  | $ | —
Segregated securities borrowed |  |  | 140 | 1 |  |  | — |  |  |  | 140 |  |  | (136) |  |  | 4
Securities borrowed |  |  | 5,845 |  |  |  | — |  |  |  | 5,845 |  |  | (5,638) |  |  | 207
Securities purchased under agreements to resell |  |  | 8,376 |  |  |  | — |  |  |  | 8,376 |  |  | (8,376) |  |  | —
Financial instruments owned, at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options |  |  | 152 |  |  |  | — |  |  |  | 152 |  |  | (100) |  |  | 52
Currency forward contracts |  |  | 1 |  |  |  | — |  |  |  | 1 |  |  | — |  |  | 1
Total |  | $ | 37,374 |  |  | $ | — |  |  | $ | 37,374 |  | $ | (37,110) |  | $ | 264
|  | (in millions)
Offsetting of financial liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities loaned |  | $ | 16,894 |  |  | $ | — |  |  | $ | 16,894 |  | $ | (15,668) |  | $ | 1,226
Financial instruments sold, but not yet purchased, at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options |  |  | 100 |  |  |  | — |  |  |  | 100 |  |  | (100) |  |  | —
Currency forward contracts |  |  | 17 |  |  |  | — |  |  |  | 17 |  |  | — |  |  | 17
Total |  | $ | 17,011 |  |  | $ | — |  |  | $ | 17,011 |  | $ | (15,768) |  | $ | 1,243
‎
|  | December 31, 2024
|  |  |  |  |  | Amounts |  |  | Net Amounts |  | Amounts Not Offset |  |  |
|  |  | Gross | Offset in the |  |  | Presented in |  | in the Condensed |  |  |
|  |  | Amounts | Condensed |  |  | the Condensed |  | Consolidated |  |  |
|  |  | of Financial | Consolidated |  |  | Consolidated |  | Statements of |  |  |
|  |  | Assets and | Statements of |  |  | Statements of |  | Financial Condition |  |  |
|  |  | Liabilities | Financial |  |  | Financial |  | Cash or Financial |  | Net
|  |  | Recognized |  | Condition | 2 |  | Condition |  | Instruments |  | Amount
|  | (in millions)
Offsetting of financial assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities segregated for regulatory purposes: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segregated securities purchased under agreements to resell |  | $ | 21,353 | 1 |  | $ | — |  |  | $ | 21,353 |  | $ | (21,353) |  | $ | —
Segregated securities borrowed |  |  | — |  |  |  | — |  |  |  | — |  |  | — |  |  | —
Securities borrowed |  |  | 5,369 |  |  |  | — |  |  |  | 5,369 |  |  | (5,159) |  |  | 210
Securities purchased under agreements to resell |  |  | 6,575 |  |  |  | — |  |  |  | 6,575 |  |  | (6,575) |  |  | —
Financial instruments owned, at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options |  |  | 84 |  |  |  | — |  |  |  | 84 |  |  | (69) |  |  | 15
Currency forward contracts |  |  | — |  |  |  | — |  |  |  | — |  |  | — |  |  | —
Total |  | $ | 33,381 |  |  | $ | — |  |  | $ | 33,381 |  | $ | (33,156) |  | $ | 225
|  | (in millions)
Offsetting of financial liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities loaned |  | $ | 16,248 |  |  | $ | — |  |  | $ | 16,248 |  | $ | (15,105) |  | $ | 1,143
Financial instruments sold, but not yet purchased, at fair value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options |  |  | 96 |  |  |  | — |  |  |  | 96 |  |  | (69) |  |  | 27
Currency forward contracts |  |  | 63 |  |  |  | — |  |  |  | 63 |  |  | — |  |  | 63
Total |  | $ | 16,407 |  |  | $ | — |  |  | $ | 16,407 |  | $ | (15,174) |  | $ | 1,233
________________________ (1)As of March 31, 2025 and December 31, 2024, the Company had $22.9 billion and $21.4 billion, respectively, of securities purchased under agreements to resell, and $140 million and $0, respectively, of securities borrowed that were segregated to satisfy regulatory requirements. These securities are included in “Securities - segregated for regulatory purposes” in the condensed consolidated statements of financial condition. (2)The Company did not have any balances eligible for netting in accordance with ASC Topic 210-20 as of March 31, 2025 and December 31, 2024. ‎ Secured Financing Transactions – Maturities and Collateral Pledged The tables below present gross obligations for securities loaned transactions by remaining contractual maturity and class of collateral pledged for the periods indicated.
|  | March 31, 2025
|  | Remaining Contractual Maturity
|  | Overnight |  | Less than |  | 30 – 90 |  | Over 90 |  |  |
|  | and Open |  | 30 days |  | days |  | days |  | Total
|  | (in millions)
Securities loaned |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stocks |  | $ | 16,835 |  | $ | — |  | $ | — |  | $ | — |  | $ | 16,835
Corporate bonds |  |  | 59 |  |  | — |  |  | — |  |  | — |  |  | 59
Total securities loaned |  | $ | 16,894 |  | $ | — |  | $ | — |  | $ | — |  | $ | 16,894
|  | December 31, 2024
|  | Remaining Contractual Maturity
|  | Overnight |  | Less than |  | 30 – 90 |  | Over 90 |  |  |
|  | and Open |  | 30 days |  | days |  | days |  | Total
|  | (in millions)
Securities loaned |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stocks |  | $ | 16,215 |  | $ | — |  | $ | — |  | $ | — |  | $ | 16,215
Corporate bonds |  |  | 33 |  |  | — |  |  | — |  |  | — |  |  | 33
Total securities loaned |  | $ | 16,248 |  | $ | — |  | $ | — |  | $ | — |  | $ | 16,248
‎

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration